Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARTL | AMGN | VRTX | REGN | BMY |
| Company | Artelo Biosciences Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.3000 | 301.75 | 406.42 | 967.88 | 43.98 |
| High | 1.3500 | 302.91 | 415.67 | 970.56 | 44.26 |
| Low | 1.2800 | 298.51 | 394.03 | 957.10 | 43.84 |
| Last | 1.2900 | 300.30 | 410.24 | 969.97 | 44.04 |
| Change | -0.0300 | +0.82 | +7.74 | +11.33 | +0.14 |
| % Change | -2.27% | +0.27% | +1.92% | +1.18% | +0.32% |
| Volume | 6,741 | 2,438,623 | 1,607,216 | 358,699 | 10,924,172 |
| 20-Day Average Volume | 9,376 | 2,798,217 | 1,091,009 | 517,626 | 14,260,399 |
| Previous Close | 1.3200 | 299.48 | 402.50 | 958.64 | 43.90 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3731 | 275.28 | 398.60 | 912.17 | 46.72 |
| 20-Day Raw Stochastic | 15.23% | 63.89% | 75.61% | 100.00% | 8.45% |
| 20-Day Relative Strength | 41.50% | 63.02% | 54.06% | 62.02% | 29.71% |
| Weighted Alpha | -25.67 | +28.09 | +17.73 | +30.72 | -36.17 |
| Today's Opinion | 72% Sell | 40% Buy | 32% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 72% Sell | 24% Buy | 8% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 24% Buy | 24% Sell | 24% Buy | 56% Buy | 32% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.48% since 04/30/24 | +9.60% since 04/30/24 | +4.29% since 04/30/24 | +8.87% since 04/30/24 | +0.15% since 04/30/24 |
| Low | 1.2602 on 05/01/24 | 273.38 on 05/01/24 | 392.47 on 05/01/24 | 888.52 on 05/01/24 | 43.33 on 05/02/24 |
| High | 1.4029 on 05/06/24 | 322.60 on 05/03/24 | 415.67 on 05/07/24 | 969.68 on 05/07/24 | 44.62 on 05/06/24 |
| 1-Month | |||||
| %Chg | -16.06% since 04/05/24 | +11.22% since 04/05/24 | +0.73% since 04/05/24 | +2.86% since 04/05/24 | -14.25% since 04/05/24 |
| Low | 1.2500 on 04/18/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 1.5999 on 04/09/24 | 322.60 on 05/03/24 | 415.67 on 05/07/24 | 969.68 on 05/07/24 | 51.68 on 04/09/24 |
| 3-Month | |||||
| %Chg | -7.00% since 02/07/24 | +1.48% since 02/07/24 | -2.25% since 02/07/24 | +3.32% since 02/07/24 | -9.53% since 02/07/24 |
| Low | 1.2500 on 04/18/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 1.7500 on 02/14/24 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -6.47% since 11/07/23 | +10.74% since 11/07/23 | +8.30% since 11/07/23 | +16.72% since 11/07/23 | -15.84% since 11/07/23 |
| Low | 1.1500 on 11/20/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 1.7500 on 02/14/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,261 | 160,633,888 | 104,029,752 | 105,222,248 | 88,989,688 |
| Shares Outstanding, K | 3,228 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -9,290,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,517,700,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -3,070,000 | -113,000,000 | 968,800,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 1.44 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.99 on 03/25/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.71 | 29.84 | 25.79 | 41.90 |